HOME >> MEDICINE >> NEWS
FDA approves Dey, L.P.'s Perforomist inhalation solution for maintenance treatment of COPD

Napa, CA (May 11, 2007) Dey, L.P. announced today that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Perforomist (formoterol fumarate) Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

Formoterol is a rapid and long-lasting beta2 agonist that has been previously approved in the U.S. as a dry powder formulation, and the molecule has twenty years of worldwide use. Perforomist Inhalation Solution is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that patients inhale through a mouthpiece or face mask.

"The first nebulized formoterol fumarate, Perforomist Inhalation Solution offers a new treatment option to COPD patients," said Nicholas J. Gross, MD, PhD, Principal Investigator of the Phase III pivotal clinical trial and an expert on lung diseases, particularly COPD. "By nebulizing with Perforomist Inhalation Solution twice a day once in the morning and once in the evening many COPD patients can achieve better control of their disease symptoms. The convenience of such simple dosing combined with a drug delivery option favored by many patients may provide improved symptom control and a better quality of life for the millions of Americans who live with COPD."

Mel Engle, President and CEO at DEY, noted, "As the US leader in nebulized respiratory products, we are thrilled to bring Perforomist Inhalation Solution, a new patented treatment option for COPD patients, to the market. Nebulization is a time tested and reliable drug delivery option. DEY has a long history of developing and marketing innovative respiratory therapeutics. The approval of Perforomist Inhalation Solution fits perfectly with our overall strategy for respiratory medications."

Gene L. Colice, MD, Department
'"/>

Contact: Harriet Ullman
harriet.ullman@fkhealth.com
617-761-6776
Feinstein Kean Healthcare
11-May-2007


Page: 1 2

Related medicine news :

1. DFG approves 11 new Collaborative Research Centers
2. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
3. VCR -- FDA approves home discharge for US patients
4. FDA approves prescription Zaditor for over-the-counter relief from itchy eyes
5. FDA approves Vectibix to treat patients with metastatic colorectal cancer
6. 5,000 rare diseases need drugs, but Europe only approves a handful each year
7. FDA approves room temperature storage of ZLB Behrings Helixate FS
8. FDA approves new indication for Topamax as initial monotherapy for adults and children with epilepsy
9. FDA approves first blood test to predict risk for stroke
10. FDA approves Boostrix a new US vaccine for adolescents against pertussis
11. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... 04, 2016 , ... Fertility Centers of New England announced today the opening ... Fertility Center provides convenient access to care for patients seeking fertility treatment in Maine. ... Wellness Comprehensive Care in Portland,” said Fertility Centers of New England President and CEO, ...
(Date:5/3/2016)... ... May 04, 2016 , ... An ... is reaching the global health community through expanding activities that embrace training, standards, ... in the resource-limited countries. , In support of this important work, ...
(Date:5/3/2016)... ... 03, 2016 , ... Today at its Annual Technology & ... Pulido, R.Ph., Co-Founder of NCPDP and member of the NCPDP Foundation Board of ... Specialist, Office of the National Coordinator for Health Information Technology (ONC). NCPDP’s Champion ...
(Date:5/3/2016)... ... 2016 , ... Calvary Hospital recently hosted a reception to mark a new ... located at Mary, Manning Walsh Home (MMW) in Manhattan. , During the school ... an hour, once a week. The music brings a lot of joy to the ...
(Date:5/3/2016)... ... 03, 2016 , ... Sandbox, one of the nation’s leading ... the newly created position of executive vice president, chief creative officer.     , In ... Chicago and LA offices. He reports to Nancy Finigan, president of those offices. ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... Mo. , May 3, 2016 ... Medical Center,s Institute for Advancing Medical Innovation (IAMI) ... commercialize new drugs, diagnostics and medical devices. ... BioNovus Innovations with rights to license, develop and ... "This partnership represents a ...
(Date:5/3/2016)... May 3, 2016   BIOTRONIK , a ... announced Food and Drug Administration (FDA) approval of ... provides heart failure patients with access to diagnostic ... have remote monitoring with daily automatic transmission and ... rate in response to physiological demands. ...
(Date:5/3/2016)... May 3, 2016 According to ... Share, Development, Growth and Demand Forecast to 2022 - ... Strength (High Field, Very High Field, Low to Mid ... and Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, ... resonance imaging (MRI) market was valued at $5,351.7 million ...
Breaking Medicine Technology:
Cached News: